{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lipid+panel&page=2", "query": { "intervention": "Lipid panel", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Lipid+panel&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-27T21:45:40.414Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02626299", "title": "Assessment of DHA On Reducing Early Preterm Birth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Preterm Birth" ], "interventions": [ { "name": "Docosahexaenoic acid - 800mg/day", "type": "DRUG" }, { "name": "Docosahexaenoic acid - 200mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1100, "start_date": "2016-06-08", "completion_date": "2020-10-05", "has_results": false, "last_update_posted_date": "2021-03-30", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 3, "location_summary": "Kansas City, Kansas • Cincinnati, Ohio • Columbus, Ohio", "locations": [ { "city": "Kansas City", "state": "Kansas" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02626299" }, { "nct_id": "NCT05236036", "title": "Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Astrocytoma", "Glioblastoma", "Glioblastoma, IDH-Wildtype", "MGMT-Unmethylated Glioblastoma", "Recurrent Glioblastoma" ], "interventions": [ { "name": "Mycophenolate Mofetil", "type": "DRUG" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Temozolomide", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER", "RADIATION" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 86, "start_date": "2022-08-08", "completion_date": "2029-01-03", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 3, "location_summary": "Chicago, Illinois • Lake Forest, Illinois • Warrenville, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Lake Forest", "state": "Illinois" }, { "city": "Warrenville", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05236036" }, { "nct_id": "NCT04121481", "title": "Clinical Study on Prodovite® VMP35 Supplement on Athletic Performance", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Athletic Performance" ], "interventions": [ { "name": "Clinical Investigation on Enhanced Sports Nutrition and Performance Activities by Prodovite VMP35 Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Broad Spectrum Safety", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Victory Nutrition International, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 150, "start_date": "2021-05-15", "completion_date": "2022-09-30", "has_results": false, "last_update_posted_date": "2021-05-07", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 1, "location_summary": "Cornelius, North Carolina", "locations": [ { "city": "Cornelius", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04121481" }, { "nct_id": "NCT02612090", "title": "The Cholesterol Lowering Effects of Strawberry", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypercholesterolemia", "Glycemic Response" ], "interventions": [ { "name": "Active Treatment Beverage", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo Treatment Beverage", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Clinical Nutrition Research Center, Illinois Institute of Technology", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "40 Years to 69 Years" }, "enrollment_count": 46, "start_date": "2016-01-04", "completion_date": "2018-10-31", "has_results": false, "last_update_posted_date": "2021-01-27", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02612090" }, { "nct_id": "NCT07811297", "title": "A Study of Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Endometrial Neoplasms", "Ovarian Neoplasms", "Soft Tissue Sarcoma (STS)", "Glioblastoma" ], "interventions": [ { "name": "AL58805", "type": "DRUG" }, { "name": "AL3818", "type": "DRUG" }, { "name": "Temozolomide (TMZ)", "type": "DRUG" }, { "name": "CCNU", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advenchen Pharmaceuticals, LLC.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 138, "start_date": "2026-09-01", "completion_date": "2031-09-01", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07811297" }, { "nct_id": "NCT04735874", "title": "Vascular Health and Risk Factors in Children With Down Syndrome", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Down Syndrome", "Cardiovascular Risk Factor", "Atherosclerosis" ], "interventions": [ { "name": "Evaluate vascular disease risk factors in children with Down Syndrome", "type": "OTHER" }, { "name": "Determine the associations between cardiovascular disease risk factors and markers of early atherosclerosis in children with Down Syndrome", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "10 Years to 18 Years" }, "enrollment_count": 55, "start_date": "2021-02-02", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT04735874" }, { "nct_id": "NCT01121484", "title": "Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Major Depressive Disorder" ], "interventions": [ { "name": "desvenlafaxine succinate sustained-release", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "40 Years to 70 Years · Female only" }, "enrollment_count": 439, "start_date": "2010-06", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2012-04-04", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 44, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Arcadia, California + 38 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Arcadia", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Chino", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01121484" }, { "nct_id": "NCT03372109", "title": "Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Body Weight Changes" ], "interventions": [ { "name": "Meal replacement shake", "type": "DIETARY_SUPPLEMENT" }, { "name": "Multivitamin and mineral capsules", "type": "DIETARY_SUPPLEMENT" }, { "name": "Fish oil with sesame lignans and olive extract softgel", "type": "DIETARY_SUPPLEMENT" }, { "name": "Prebiotic Chewable tablet", "type": "DIETARY_SUPPLEMENT" }, { "name": "Clove Extract and Maqui Berry extract capsule", "type": "DIETARY_SUPPLEMENT" }, { "name": ".Whole Food Blend capsule", "type": "DIETARY_SUPPLEMENT" }, { "name": "Turmeric extract capsule", "type": "DIETARY_SUPPLEMENT" }, { "name": "European White Kidney Bean capsule", "type": "DIETARY_SUPPLEMENT" }, { "name": "Saffron extract capsule", "type": "DIETARY_SUPPLEMENT" }, { "name": "Ubiquinol with Fulvic acid complex softgel", "type": "DIETARY_SUPPLEMENT" }, { "name": "Calcium with Hesperidin and gynostemma extract tablet", "type": "DIETARY_SUPPLEMENT" }, { "name": "Multivitamin and mineral supplement", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Supplement Formulators, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 23, "start_date": "2017-11-14", "completion_date": "2018-03-22", "has_results": false, "last_update_posted_date": "2018-04-17", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 1, "location_summary": "Fort Lauderdale, Florida", "locations": [ { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03372109" }, { "nct_id": "NCT01019395", "title": "Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gram Positive Bacterial Infection" ], "interventions": [ { "name": "Daptomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Months", "maximum_age": "24 Months", "sex": "ALL", "summary": "3 Months to 24 Months" }, "enrollment_count": 23, "start_date": "2010-01-05", "completion_date": "2012-03-20", "has_results": false, "last_update_posted_date": "2019-11-13", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 8, "location_summary": "Little Rock, Arkansas • Orange, California • San Diego, California + 5 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Shreveport", "state": "Louisiana" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01019395" }, { "nct_id": "NCT01413620", "title": "Vitamin E Supplementation in Burn Patients", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Burn Injury" ], "interventions": [ { "name": "dl-alpha-tocopheryl acetate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Shriners Hospitals for Children", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": "85 Years", "sex": "ALL", "summary": "6 Months to 85 Years" }, "enrollment_count": 0, "start_date": "2011-08", "completion_date": "2021-08", "has_results": false, "last_update_posted_date": "2021-09-21", "last_synced_at": "2026-09-27T21:45:40.414Z", "location_count": 1, "location_summary": "Galveston, Texas", "locations": [ { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01413620" } ] }